Margareth C. Ozelo

Universidade Estadual de Campinas (UNICAMP) — Brazil

Medicine · Health Sciences

34h-index7.0kcitations226works5.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hemophilia Treatment and Research(129), Platelet Disorders and Treatments(51), Blood Coagulation and Thrombosis Mechanisms(44), Virus-based gene therapy research(21), Myeloproliferative Neoplasms: Diagnosis and Treatment(20)

Publications226 total

Impact of Fidanacogene Elaparvovec Gene Therapy on Joint Health in Adults With Haemophilia B: Results From a Phase 3 Study
Haemophilia·2025
HTRS2025.O8C.3 Alfa-PROTECT: A Phase 3, Open-Label Study to Evaluate the Safety of Damoctocog Alfa Pegol in Previously Treated Children Aged 7 to <12 Years With Severe Hemophilia A
Research and Practice in Thrombosis and Haemostasis·2025Open Access
HTRS2025.P1.9 Safety of Damoctocog Alfa Pegol in Patients With Severe Hemophilia A Aged 7 to <12 years of age; Pooled Data From PROTECT VIII Kids and Alfa-PROTECT
Research and Practice in Thrombosis and Haemostasis·2025Open Access
Long-term durability of rAAV gene therapy in hemophilia: Factor expression, clinical outcomes and underlying molecular mechanisms
Blood Reviews·2025Open Access
The WFH Guidelines for the Management of Haemophilia: AAV Gene Therapy, 2025
Haemophilia·2025· 3 citedOpen Access
IMPACTO DA IDADE E DO SEXO NA APLICAÇÃO DO ISTH-BAT EM POPULAÇÃO PEDIÁTRICA SAUDÁVEL
Hematology Transfusion and Cell Therapy·2025Open Access
DIFERENÇAS NA RESPOSTA IMUNE DA SÍNDROME E WISKOTT ALDRICH E DA TROMBOCITOPENIA LIGADA AO X E SUAS POSSÍVEIS IMPLICAÇÕES PARA INDICAÇÃO AO TRANSPLANTE DE CÉLULAS-TRONCO HEMATOPOIÉTICAS (TCTH)
Hematology Transfusion and Cell Therapy·2025Open Access
New insights into Wiskott-Aldrich syndrome: ten novel WAS mutations and their clinical impact in a Brazilian cohort
Frontiers in Immunology·2025Open Access
Plain language summary of 4-year results of the GENEr8-1 clinical trial of valoctocogene roxaparvovec gene therapy for hemophilia A
Future Rare Diseases·2025
Activated prothrombin complex concentrate in patients receiving emicizumab prophylaxis: from evidence to clinical practice
Research and Practice in Thrombosis and Haemostasis·2025· 2 citedOpen Access
Global Comparative Antithrombin Field Study: Impact of Laboratory Assay Variability on the Assessment of Antithrombin Activity Measurement at Fitusiran Clinical Decision‐Making Points
Haemophilia·2025· 1 citedOpen Access
Corticosteroid use to mitigate transaminitis-associated decline in FVIII levels following valoctocogene roxaparvovec gene therapy: clinical practice guidance
Journal of Thrombosis and Haemostasis·2025· 4 citedOpen Access
Health-related quality-of-life outcomes 4 years after treatment with valoctocogene roxaparvovec
Hämostaseologie·2025
Efficacy and safety of valoctocogene roxaparvovec 4 years after gene transfer in GENEr8-1
Hämostaseologie·2025· 1 cited
Clinical trials to gene therapy development and production in Brazil: a review
The Lancet Regional Health - Americas·2025· 6 citedOpen Access
Safety and efficacy of valoctocogene roxaparvovec with prophylactic glucocorticoids: 1-year results from the phase 3b, single-arm, open-label GENEr8-3 study
Journal of Thrombosis and Haemostasis·2025· 9 cited
Contrasting Approaches in the Implementation of GRADE Methodology in Guidelines for Haemophilia and Von Willebrand Disease
Haemophilia·2024· 4 citedOpen Access
International Society on Thrombosis and Haemostasis Clinical Practice Guideline for Treatment of Congenital Haemophilia—A Critical Appraisal
Haemophilia·2024· 6 citedOpen Access
Maior reposição de Fator VIII (FVIII) da coagulação em pacientes com Hemofilia A moderada dos grupos sanguíneos não-O
Research Society and Development·2024Open Access
Efficacy, safety, and quality of life 4 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A in the phase 3 GENEr8-1 trial
UNC Libraries·2024Open Access
page 1 of 12Next →

Frequent Co-authors

Johnny Mahlangu(10), Margaret V. Ragni(8), Glenn F. Pierce(6), Erich Vinícius De Paula(6), Joyce Maria Annichino‐Bizzacchi(6), Valder R. Arruda(5), John Pasi(5), Flora Peyvandi(5), Johannes Oldenburg(5), Alvin Luk(4), Haiyan Jiang(4), Katherine A. High(4), Gili Kenet(4), Andrew D. Leavitt(4), Hérvè Chambost(4), David Lillicrap(4), Robert Klamroth(4), Amy D. Shapiro(4), Cédric Hermans(4), Roshni Kulkarni(4)